Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 11;9(32):6639-6646.
doi: 10.1039/c8sc02253d. eCollection 2018 Aug 28.

Silyl-mediated photoredox-catalyzed Giese reaction: addition of non-activated alkyl bromides

Affiliations

Silyl-mediated photoredox-catalyzed Giese reaction: addition of non-activated alkyl bromides

Abdellatif ElMarrouni et al. Chem Sci. .

Abstract

The emergence of photoredox catalysis has enabled the discovery of mild and efficient conditions for the generation of a variety of radical reaction platforms. Herein is disclosed the development of a conjugate addition reaction of non-activated alkyl bromides to Michael acceptors under visible-light photoredox catalysis. Optimization of the reaction was achieved using high-throughput experimentation (HTE) tools to enable the identification of mild, general and practical reaction conditions. A diverse set of alkyl bromides was successfully added to cyclic or acyclic α,β-unsaturated esters and amides. The features of this transformation allowed also access to a key intermediate of Vorinostat®, an HDAC inhibitor used to fight cancer and HIV.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1. Synthesis of C–C bonds through photocatalytic Giese reaction.
Fig. 1
Fig. 1. Photocatalyst and solvent screening: N-phenylmetacrylamide (1), (4-bromopiperidin-1-yl)(phenyl)methanone (2), Na2CO3 (2.0 equiv.), (Me3Si)3SiH, photocatalyst (1 mol%), Aldrich® Micro Photochemical Reactor (ring) for 16 h. [a] Assay yields for desired product was determined using standard HPLC techniques.
Fig. 2
Fig. 2. Reactant ratio screening: N-phenylmetacrylamide (1), (4-bromopiperidin-1-yl)(phenyl)methanone (2), Na2CO3 (2.0 equiv.), (Me3Si)3SiH, Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1 mol%) in MeOH, Aldrich® Micro Photochemical Reactor (ring) for 16 h. [a] Assay yields for desired product was determined using standard HPLC techniques.
Fig. 3
Fig. 3. Visible-light source comparison: N-phenylmetacrylamide (1) (1.0 equiv.), (4-bromopiperidin-1-yl)(phenyl)methanone (2) (1.5 equiv.), Na2CO3 (2.0 equiv.), (Me3Si)3SiH, Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1 mol%) in MeOH. [a] Assay yields for desired product was determined using standard HPLC techniques. [b] Ring = Aldrich® Micro Photochemical Reactor. [c] Lamp = Kessil® A160WE Tuna Blue Light. [d] Reactor = 13.2W Merck Photoreactor.
Scheme 2
Scheme 2. Plausible mechanism.
Scheme 3
Scheme 3. Deuterated NMR experiments: (A) control experiment; (B) reaction of amide 1 with t-butyl bromide using deuterated reagents.
Scheme 4
Scheme 4. Versatile approach to Vorinostat® through photocatalytic conjugate addition. [a] 48 (1.0 equiv.), 47 (3.0 equiv.), Na2CO3 (2.0 equiv.), (Me3Si)3SiH (0.75 equiv.) and Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1 mol%) in MeOH, integrated photoreactor (reactor), 1 h.

References

    1. Cernak T., Dykstra K. D., Tyagarajan S., Vachal P., Krska S. W. Chem. Soc. Rev. 2016;45:546. - PubMed
    2. Roughley S. D., Jordan A. M. J. Med. Chem. 2011;54:3451. - PubMed
    3. Jordan A. M., Roughley S. D. Drug Discovery Today. 2009;14:731. - PubMed
    4. Carey J. S., Laffan D., Thomson C., Williams M. T. Org. Biomol. Chem. 2006:2337. - PubMed
    1. See review and references therein: Geist E., Kirschning A., Schmidt T., Nat. Prod. Rep., 2014, 31 , 441 . - PubMed
    2. Cardenas D. Angew. Chem., Int. Ed. 2003;42:384. - PubMed
    1. For selected reviews on 1,4-conjugate additions, see:

    2. Perlmutter P., Conjugate Addition Reactions in Organic Synthesis, Pergamon, Oxford, 1992.
    3. Schmalz H.-G., in Comprehensive Organic Synthesis, ed. B. M. Trost and I. Fleming, Pergamon Press, Oxford, 1991, vol. 4, ch. 1.5.
    1. For selected reviews:

    2. Schultz D. M., Yoon T. P. Science. 2014;343:941. - PMC - PubMed
    3. Prier C. K., Rankic D. A., MacMillan D. W. C. Chem. Rev. 2013;113:5322. - PMC - PubMed
    4. Yoon T. P. ACS Catal. 2013;3:895. - PMC - PubMed
    5. Xi Y., Yi H., Lei A. Org. Biomol. Chem. 2013;11:2387. - PubMed
    6. Reckenthler M., Griesbeck A. G. Adv. Synth. Catal. 2013;355:2727.
    7. Garlets Z. J., Nguyen J. D., Stephenson C. R. J. Isr. J. Chem. 2014;54:351. - PMC - PubMed
    8. Douglas J. J., Nguyen J. D., Cole K. P., Stephenson C. R. J. Aldrichimica Acta. 2014;47:15.
    9. Nicewicz D. A., Nguyen T. M. ACS Catal. 2014;4:355.
    1. Giese B., Dupuis J. Angew. Chem., Int. Ed. Engl. 1983;22:622.
    2. Giese B. Angew. Chem., Int. Ed. Engl. 1983;22:753.
    3. Giese B., Gonzalez-Gomez J. A., Witzel T. Angew. Chem., Int. Ed. Engl. 1984;23:69.
    4. Jasperse C. P., Curran D. P., Fevig T. L., Chem. Rev., 1991, 91 , 1237 , For seminal work on the addition of alkyl radicals to Michael acceptors involving a photoactive metal complex see: .
    5. Okada K., Okamoto K., Morita N., Okubo K., Oda M., J. Am. Chem. Soc., 1991, 113 , 9401 , For a specific example involving an alkyl bromide under photoredox conditions, see: .
    6. Zhou S., Zhang D., Sun Y., Li R., Zhang W., Li A. Adv. Synth. Catal. 2014;356:2867.